Pacific's Osteopatch enters US trial:
This article was originally published in Clinica
Executive Summary
Pacific Biometrics has completed pilot clinical studies of the Osteopatch skin patch, designed for management of osteoporotic disease. The non-invasive system consists of a patented transdermal sweat collection device, assays for bone loss markers in sweat and a proprietary method for laboratory analysis. A US trial in 300 patients will begin soon and will take three to four months to complete, after which the company will make a 510(k) filing. 28 million people in the US are at risk for osteoporosis, a number that the National Osteoporosis Foundation believes will grow to 41 million by 2015.